On the other hand, no changes were observed in Tau pathology in the rTg4510 [63] or 3xTg-AD [64] models after a 30% microglial depletion using the pharmacological inhibitors PLX3397 and PLX5562, respectively. Here, MAPT is linked to Alzheimer disease.